SYRE
SYRE
NASDAQ · Biotechnology

Spyre Therapeutics Inc

$103.42
-0.93 (-0.89%)
Analyst Consensus
Strong Buy
23
Analysts
High
Coverage
Buy 22 96%
Hold 1 4%
Sell 0 0%
Price Target
Analyst Price Target -23.7% upside
Low Target $58.92
Average Target $78.92
High Target $128.60
Current Price $103.42
Current
$103.42
Target
$78.92
$58.92 $78.92 avg $128.60
Scenario Analysis
Bear Case
$58.92
-43.0%
Low target
Base Case
$78.92
-23.7%
Avg target
Bull Case
$128.60
+24.3%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$105.09
-1.6% from high
52-Week Low
$14.51
+613.0% from low
50-Day SMA
$33.24
+211.1% vs SMA
200-Day SMA
$22.06
+368.8% vs SMA
RSI (14)
64.7
Neutral
Target vs 52W High
$78.92
-24.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 79% $257.58 +5.4%
AMGN
Amgen Inc
Hold 43 49% $190.87 -52.7%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +179.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -9.5%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -90.0%
RVMD
Revolution Medicines Inc
Strong Buy 29 93% $114.11 -42.1%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -46.0%
BIIB
Biogen Inc
Buy 44 64% $91.45 -55.7%